Molecure Receives Positive IDMC Recommendation to Continue the KITE Clinical Trial Without Changes to the Study Protocol (OATD-01 Development Program)

Phase 2positiveOATD-01Positive

AI Analysis

Summary

Molecure's Phase 2 KITE trial for OATD-01 in pulmonary sarcoidosis received a positive IDMC recommendation to continue without protocol changes, indicating positive interim safety and efficacy monitoring.

Clinical Trial Data

Phase

Phase 2

Outcome Details

IDMC recommendation to continue trial without protocol changes

Importance:5/10

Sentiment:

0.70

OATD-01pulmonary sarcoidosisPhase 2IDMCKITE trial

Related Companies

$GILD

Read the original article

Published by GlobeNewswire Clinical Studies on August 3, 2026 4:02 PM

Read Original